Showing 161 - 180 results of 306 for search 'International Association for the Study of Obesity', query time: 0.08s Refine Results
  1. 161
  2. 162
  3. 163

    Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes by Ruo-Yao Gao, Bang-Gee Hsu, Du-An Wu, Jia-Sian Hou, Ming-Chun Chen

    Published 2019-01-01
    “…Multivariate forward stepwise linear regression analysis revealed that body fat mass (adjusted R2 change = 0.218; P=0.008) and log-TG (adjusted R2 change = 0.036; P<0.001) positively correlated, whereas eGFR (adjusted R2 change = 0.033; P=0.013) negatively correlated with serum FGF21 levels in T2DM patients. Conclusions. This study showed that higher serum FGF21 levels were positively associated with MetS in T2DM patients and significantly positively related to body fat mass and TG but negatively related to eGFR in these subjects.…”
    Get full text
    Article
  4. 164

    Patterns and Factors Associated with Dyslipidemia Among Patients with Diabetes Mellitus Attending Hoima Regional Referral Hospital, Uganda by Hirsi AM, Abdi AA, Peris A, Jacinto A, Muhammad P, Nur IA, Mohamud MH, Hussein M, Qaws A, Jayte M

    Published 2025-01-01
    “…All diabetes patients who were overweight or obese had dyslipidemia (p < 0.001).Conclusion: The most common pattern of dyslipidemia in patients with diabetes was elevated total cholesterol, followed by high low-density lipoprotein, associated with overweight, obesity, female gender, and CHD. …”
    Get full text
    Article
  5. 165
  6. 166

    High Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes by Jer-Chuan Li, Du-An Wu, Jia-Sian Hou, Yi-Maun Subeq, Hsin-Dean Chen, Bang-Gee Hsu

    Published 2016-01-01
    “…Adipocyte fatty acid binding protein (A-FABP) is a key mediator of obesity-related metabolic syndrome (MetS). The aim of this study was to evaluate the relationship between A-FABP concentration and MetS in type 2 diabetes mellitus (DM) patients. …”
    Get full text
    Article
  7. 167
  8. 168
  9. 169
  10. 170

    Binge eating disorder recognition and stigma among an adult community sample by Marilou Côté, Marie-Pier Roy, Christopher Rodrigue, Catherine Bégin

    Published 2025-01-01
    “…The aim of the present study was to examine BED recognition and stigma within an adult community sample, and to identify associated respondent characteristics, including sociodemographic and psychosocial factors. …”
    Get full text
    Article
  11. 171
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179

    Perceptions of Weight and Health Practices in Hispanic Children: A Mixed-Methods Study by Byron Alexander Foster, Daniel Hale

    Published 2015-01-01
    “…Perception of weight by parents of obese children may be associated with willingness to engage in behavior change. …”
    Get full text
    Article
  20. 180

    Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study by Atsushi Nakajima, Yasushi Honda, Kento Imajo, Masato Yoneda, Yuji Ogawa, Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, Asako Nogami, Satoru Saito, Michihiro Iwaki, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Yuki Kasai, Noritoshi Kobayashi

    Published 2022-07-01
    “…The primary endpoint will be the percentage reduction in hepatic fat content (%) measured using MRI-proton density fat fraction from baseline by at least 3.46% at week 16 after treatment initiation.Ethics and dissemination Ethics approval was obtained from the Ethics Committee of Yokohama City University Hospital before participant enrolment (YCU021001). The results of this study will be submitted for publication in international peer-reviewed journals, and the key findings will be presented at international scientific conferences. …”
    Get full text
    Article